Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD), the recently introduced terminology superseding non-alcoholic fatty liver disease (NAFLD), has emerged as the most prevalent chronic liver condition globally. This multisystem disorder, driven by systemic insulin resistance (...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer
2026-05-01
|
| Sarja: | Molecular Biomedicine |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s43556-026-00486-5 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|